New Enterprise Associates 16, L.P. Metacrine, Inc. (MTCR) insider trading activity

New Enterprise Associates 16, L.P. is > 10% Shareholder of Metacrine, Inc.. Currently has a direct ownership of 2.56 Million shares of MTCR, which is worth approximately $0. The most recent transaction as insider was on Dec 22, 2021, when has been sold 459,700 shares (Common Stock) at a price of $0.96 per share, resulting in proceeds of $441,312. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.56M

0% 3M change

0% 12M change

Total Value Held $0

New Enterprise Associates 16, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 22 2021	SELL Open market or private sale	$441,312 $0.96 p/Share	459,700 Reduced 15.21%	2,563,257 Common Stock
Dec 10 2021	SELL Open market or private sale	$49,592 $1.32 p/Share	37,570 Reduced 1.23%	3,022,957 Common Stock

Also insider at

BHG

Bright Health Group Inc. Healthcare

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

AKUS

Akouos, Inc. Healthcare

> 10% Shareholder

TRVI

Trevi Therapeutics, Inc. Healthcare

> 10% Shareholder

MRKR

Marker Therapeutics, Inc. Healthcare

> 10% Shareholder

GNCA

GENOCEA BIOSCIENCES, INC. Healthcare

> 10% Shareholder

NEA